Astrotech Reports Third Quarter of Fiscal Year 2025 Financial Results

1 day ago

AUSTIN, Texas, May 13, 2025 (GLOBE NEWSWIRE) -- Astrotech Corporation (Nasdaq: ASTC) (the “Company” or “Astrotech”) reported its financial results…

Vivani Medical Provides Business Update Including $3M Equity Financing and Reports First Quarter 2025 Financial Results

1 day ago

All subjects in the NPM-115 cohort had successful insertions of a miniature, ultra long-acting GLP-1 (exenatide) implant in the on-going…

Metagenomi Reports Business Updates and First Quarter 2025 Financial Results

1 day ago

- Nonhuman primate (NHP) study in hemophilia A demonstrated therapeutically relevant factor VIII (FVIII) activity with durable response through approximately…

Tempest Reports First Quarter 2025 Financial Results and Provides Business Update

1 day ago

Presented new amezalpat mechanism-of-action data reinforcing its potential as a novel cancer treatment at the 2025 AACR Annual MeetingGranted Orphan…

Pixalate’s April 2025 Top Grossing Mobile and CTV Apps in North America: ‘Happy Color’ Ranked No. 1 on Apple App Store in Canada; ‘Hulu’ No. 1 Across Roku, Amazon Fire TV, Samsung Smart TV, & Apple TV in U.S.

1 day ago

According to Pixalate's research, the app ‘Happy Colors’ in Canada generated an estimated $282K in open programmatic ad revenue on…

Satellogic Reports First Quarter 2025 Financial Results and Provides Business Update

1 day ago

Revenue of $3.4 million in 1Q 2025 Domestication to U.S. Completed Awarded $30 Million Contract for AI-First Constellation and Closed…

Pixalate’s April 2025 Top Grossing Mobile & CTV Apps in EMEA: ‘Block Blast!’ Tops Apple App Store in UK, Germany; ‘SimCity’ Led on Google Play Store in UK, Spain, Germany

1 day ago

According to Pixalate's research, ‘Pro Des Mots’ led on Apple App Store in France, ‘Sudoku’ was No. 1 in Israel…

GEN Restaurant Group Announces First Quarter 2025 Financial Results

1 day ago

CERRITOS, Calif., May 13, 2025 (GLOBE NEWSWIRE) -- GEN Restaurant Group, Inc. (“GEN” or the “Company”) (Nasdaq: GENK), owner of…

Checkpoint Therapeutics Reports First Quarter Financial Results and Recent Corporate Updates

1 day ago

UNLOXCYT™ (cosibelimab-ipdl) approved by U.S. FDA in December 2024 as first and only anti-PD-L1 treatment for advanced cutaneous squamous cell carcinoma…

This website uses cookies.